Michael Behr is an experienced life science executive with a demonstrated history of success in building start-ups from concept through commercialization. They founded and served as President of CD Diagnostics from 2008 to 2012, leading the development of innovative medical devices. Michael is currently the Chief Executive Officer at Prolifagen and an Angel Investor with Broad Street Angels, focusing on life science start-up companies. Additionally, they held the position of VP, East US at OrthAlign, Inc. from 2014 to 2023 and serve on the Board of Directors for Orthoforge Inc. Michael earned a BS in Athletic Training from West Chester University of Pennsylvania and an MBA in General Management from Saint Joseph's University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices